Clinical utility and cost-effectiveness of genome sequencing for refractory epilepsy in children and adults: a multicentre randomised controlled trial

  • Kwan, Patrick (Primary Chief Investigator (PCI))
  • Petrovski, Slavé (Chief Investigator (CI))
  • Ratcliffe, Julie (Chief Investigator (CI))
  • Winship, Ingrid M. (Chief Investigator (CI))
  • Mullen, Saul Alator (Chief Investigator (CI))

Project: Research

StatusActive
Effective start/end date1/01/1831/12/21

Funding

  • National Health & Medical Research Council (NHMRC): AUD730,697.23